Evidence map›Paper›PMID 30766757›Full record

ArticleCancer biology & medicine2018

2017 Chinese expert consensus on the clinical application of serum marker for thyroid cancer.

Ming Gao, Minghua Ge, Qinghai Ji, Ruochuan Cheng, Hankui Lu, Haixia Guan, Wei Cui, Li Gao, Zairong Gao, Lin Guo and 19 more

Abstract read
In one paragraph

Article in Cancer biology & medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Ultrasound features of medullary thyroid cancer as predictors of biological behavior.Cancer imaging : the official publication of the International Cancer Imaging Society · 2021
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Ming GaoDepartment of Head and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital; National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China.
Minghua GeDepartment of Head and Neck, Zhejiang Cancer Hospital, Hangzhou 310022, China.
Qinghai JiDepartment of Head and Neck Tumor, Fudan University Shanghai Cancer Center, Shanghai 200433, China.
Ruochuan ChengDepartment of General Surgery, First Affiliated Hospital of Kunming Medical University, Kunming 650032, China.
Hankui LuDepartment of Nuclear Medicine, The Sixth Affiliated Hospital of Shanghai Jiao Tong University, Shanghai 200025, China.
Haixia GuanDepartment of Endocrinology, The First Hospital of China Medical University, Shenyang 110001, China.
Wei CuiDepartment of Clinical Laboratory, Cancer Hospital Chinese Academy of Medical Science, Beijing 100021, China.
Li GaoDepartment of Head and Neck, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310020, China.
Zairong GaoDepartment of Nuclear Medicine, Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan 430030, China.
Lin GuoDepartment of Clinical Laboratory, Fudan University Shanghai Cancer Center, Shanghai 200433, China.
Zhuming GuoSun Yat-sen University Cancer Center, Guangzhou 510060, China.
Tao HuangDepartment of Thyroid and Breast, Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan 430030, China.
Xiaoming HuangDepartment of Otolaryngology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China.
Yansong LinDepartment of Nuclear Medicine, Peking Union Medical College Hospital, Beijing 100730, China.
Qinjiang LiuDepartment of Head and Neck, Gansu Provincial Cancer Hospital, Lanzhou 730050, China.
Xin NiDepartment of Head and Neck, Beijing Children's Hospital, Capital Medical University, Beijing 100045, China.
Jianwu QinDepartment of Thyroid, Head and Neck, Henan Cancer Hospital, Zhengzhou 450008, China.
Li RenDepartment of Clinical Laboratory, Tianjin Medical University Cancer Institute and Hospital; National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China.
Zhongyan ShanDepartment of Endocrinology, The First Hospital of China Medical University, Shenyang 110001, China.
Hui SunDepartment of Thyroid, Sino Japanese Union Hospital of Jilin University, Changchun 130033, China.
Xudong WangDepartment of Head and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital; National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China.
Zhengang XuDepartment of Head and Neck, Cancer Hospital Chinese Academy of Medical Sciences, Beijing 100021, China.
Yang YuDepartment of Head and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital; National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China.
Bin ZhangDepartment of Head and Neck, Peking Union Medical College Hospital, Beijing 100730, China.
Daiwei ZhaoDepartment of General Surgery, The Second Affiliated Hospital of Guizhou Medical University, Kaili 556099, China.
Ying ZhengDepartment of Head and Neck, Jilin Tumor Hospital, Changchun 130012, China.
Jingqiang ZhuDepartment of Thyroid and Breast, West China School of Medicine, West China Hospital, Sichuan University, Chengdu 610047, China.
Xiangqian ZhengDepartment of Head and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital; National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China.
Chinese Association Of Thyroid Oncology Cato China Anti-Cancer AssociationDepartment of Head and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital; National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID30766757
PMCPMC6372917

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.